Skip to main content
. 2025 Jun 12;111(9):6162–6171. doi: 10.1097/JS9.0000000000002714

Table 3.

Pathological response rates

Major pathological response Pathological complete response
Intention-to-treat population 16/31(51.6%) 7/31(22.6%)
Cancer type*
 Adenocarcinoma 6(37.5%) 2(28.6%)
 Squamous cell carcinoma 10(62.5%) 5(71.4%)
P value 0.317 0.257
Preoperative nodal stage
 N1 12(75%) 4(57.1%)
 N2 4(25%) 3(42.9%)
P value 0.046 0.705
Stage at presentation
 IIA or IIB 12(75%) 4(57.1%)
 IIIA 4(25%) 3(42.9%)
P value 0.046 0.705

Data are n/N (%) unless otherwise indicated.

*

Only includes patients who underwent successful R0 surgical resection.